In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

When it's late but not 'too late' in heart failure

ESC Congress 2010

Heart Failure

Prof. Ceconi from Ferrara discussed the approaches to managing patients with CAD and HF as a result of infarction and ischaemia. His talk reviewedthe various revascularisations options and discussed which options would be most appropriate in the individual patients.

M. Boehm from Hamburg, reviewed the importance of tachycardia both as a manifestation and potential aggravating factor in patients with HF. He reviewed the results of the SHIFT trial which had been presented at the HL session earlier that day and demonstrated the potential efficacy of HR reduction.

Prof Tsutsui from Sapporo, discussed the medical treatment of HF. He reviewed both conventional management and presented an overview of promising new agents and discussed their potential role in different patient categories.

Prof. Jessup from Philadelphia, presented an overview of our experience with ventricular assist devices. The potential benefits, limitations and pitfalls of various devices were reviewed. There is a rapid development of technology in this field. It is expected that these developments along with deeper understanding of the appropriate patient population will lead to more extensive use of ventricular support in the future.




When it's late but not 'too late' in heart failure
The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.